Instrument Inactif

Communiqués Neovasc Inc Toronto S.E.

Actions

Neovasc : Notice of Change in Corporate Structure - Form 6-K	12/04/23	PU
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	03/04/23	AQ
Neovasc: Q4 Earnings Snapshot	31/03/23	AQ
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	31/03/23	GL
Neovasc : Shareholders Approve Acquisition by Shockwave Medical	06/03/23	PU
Neovasc Announces German Reimbursement Renewal	01/02/23	AQ
Neovasc : Notice of the Meeting and Record Date - Form 6-K	27/01/23	PU
IIROC Trade Resumption - NVCN	17/01/23	AQ
IIROC Trading Halt - NVCN	17/01/23	AQ
Shockwave Medical Announces Agreement to Acquire Neovasc	17/01/23	AQ
Shockwave Medical to Acquire Neovasc	17/01/23	AQ
Neovasc Announces Progress on COSIRA-II Clinical Trial	28/11/22	AQ
Neovasc Comments on European Heart Journal Publication	18/11/22	AQ
Neovasc: Q3 Earnings Snapshot	11/11/22	AQ
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update	10/11/22	AQ
Neovasc Reducer Obtains U.S. Outpatient Reimbursement	08/11/22	AQ
Neovasc to Report Third Quarter Financial Results on November 10, 2022	27/10/22	AQ
Neovasc : New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease - Form 6-K	20/09/22	PU
Neovasc Provides Corporate Update Following Clinical Data Release	20/09/22	AQ
Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit	16/09/22	AQ

Aucun résultat pour cette recherche